RESEARCH GRANT AWARDS
AWARDS LIST.
Totals by Year
2023 - $891,364
2022 - $1,199,966
2021 - $749,812
2020 - $630,000
2019 - $690,000
2018 - $750,000
2017 - $747,772
2016 - $720,000
2015 - $840,000
2014 - $810,000
2013 - $808,500
2012 - $720,000
2011 - $599,780
2010 - $438,000
2009 - $435,000
2008 - $619,993
2007 - $232,600
2006 - $384,551
Amounts flagged (*) below are 50% funded by Cancer League of Colorado and 50% matched by MDC/RICHMOND AMERICAN HOMES FOUNDATION.
Ke Jun Han PhD with Changwei Liu
Regulating EGFR protein levels by a deubiquitinaying enzyme in cancer cells
30,000
2013
Nicholas Foreman MD
Development of Antibody as immunotherapy for pediatric brain tumors
30,000
2013
John Tentler PhD
Cancer Research Fellowship Program
$30,000
2013
Chu An Wang, Dept. of Pharm.
Targeting Vascular Endothelial Growth Factor C in the cancer stem like population sensitizes breast Ccncer cells to oxidize stress and onhibits tumor progression
30,000
2013
Steven Anderson and Mary Reyland
Protein Kinase C Delta and breast cancer therapeutics
30,000
2013
Quinghong Zang PhD
Targeting Melanoma Photocinogeneses by blocking C+BP1
30,000
2013
Robert Keith MD with Gregory Hickey, Fellow
Pre-Clinical Investigation of Treprostinil as a Cemopreventive Agent for non-small cell lung cancer
30,000
2013
York Miller MD and Mark Geraci MD
Bronchial Somatic Chromosomal Alterations in lung cancer risk
30,000
2013
Elizabeth Kessler MD, Fellow
Effects of Androgen Deprivation Therapy on geriatric health and physical function in men over 70 years of age with prostate cancer
30,000
2013
Joy Hesselberth PhD
Defining the role of SF 381 mutations in Leukemia
30,000
2013
Thomas Rodger, postdoctoral fellow
Targeting the Kynurenine Pathway to inhibit breast cancer metastases
30,000
2013
Pepper Schedin, PhD
Investigating the role of lymphangiogenesis and lymphovascular invasion in metastasis of postpartum breast cancer
30,000
2012
David Astling, PhD
Development of an Improved Classifier for Predicting Multiple Drug Classes and Molecular Targets for Tumor Subtypes
30,000
2012
Peter Kabos, MD
Role of alternative polyadenylation in estrogen receptor positive breast cancer
30,000
2012
Uday Kompella, PhD
Novel Lung Cancer Therapeutics
30,000
2012
Ann Thor, MD/ Reema Wahdan-Alaswad, PhD
Metformin Inhibits Metastasis in Triple Negative Breast Cancer
30,000
2012
Jill Slansky, PhD Tullio Bruno, PhD
Characterizing the Function and Location of B Cells in Lung Cancer
30,000
2012
Shi-Long Lu, PhD
Tumor cell Dissemination and Metastasis Initiation in Head and Neck Cancer
30,000
2012
Michelle Guney, PhD
The Role of Eya in breast cancer metastic progression
30,000
2012
Bolin Liu, MD
Epignetic induction of erbB2/erbB3-targeting miRNAs in breast cancer
30,000
2012
Eduardo Pajon, MD
Colorado Cancer Research Program
30,000
2012
Catherine Musselman, PhD
The Role of PHF1 in the repressive activity of PRC2
30,000
2012
Michael J. Morgan, PhD
Autophagy Dependence and Chloroquine Sensitivity in Metastatic Cancer
30,000
2012
Rui Zhao, PhD Quinghong Zhang, PhD
Inhibiting the transcriptional co-repressor CtBP for cancer therapy using cell penetrating peptide
60,000
2012
Jingshi Shen, PhD
Dissection of the perforin pathway in cancer immunotherapy
30,000
2012
Colin Moore, MD
Evaluating the Role of miR 193b in Ewing Sarcoma growth Suppression
30,000
2012
Caroline Kulesza, PhD
Virus Manipulation of a Cellular Chromatin Modifying Complex
30,000
2012
Jordan Jacobelli, PhD
Regulation of lymphoma dissemination by the actin-myosin cytoskeleton
30,000
2012
Amanda Guth, DVM, PhD
Monocyte Blockade with CCR2 Antagonists for Inhibition of tumor metastases
30,000
2012
Robert Doebele, MD, PhD Kurtis D. Davies, PhD
Acquired Resistance to ROS1 inhibition in Non-Small Cell Lung Cancer: Identification of Cellular Mechanisms and Exploration of Alternative Treatment Strategies
30,000
2012
Stephen Malkoski, MD Scott Cramer, PhD
Defining the role of TAK1 in non-small cell lung cancer
60,000
2012
Marileila Varella Garcia, PhD
2012 Cancer Research Summer Fellowship Program
30,000
2012
Antonio Jimeno, MD, PhD Gregory Gan, MD, PhD
Resistance of Human Head and Neck Squamous Cell Carcinoma to Concurrent EGFR and Radiotherapy Mediated Through the Hedgehog Pathway
30,000
2012
Dawn Duval, Ph.D.
Osteosarcoma: Biomarkers of Metastasis and Resistance to Therapy
30,000
2011
James Lambert, Ph.D.
Genome-wide RA interference screen for mediators of cell death induced by a novel vitamin D analog in triple negative breast cancer
30,000
2011
Kim Jihye, Ph.D.
PathCMap Development of pathway signature system for identifying partners of synethetic lethal genes
30,000
2011
Sunshine Axlund, Ph.D.
Tumor initiating and Drug Resistant Properties of a minor Population of Stem-Like Cells in Explant Models of Estrogen Receptor Positive Human Breast Tumors
30,000
2011
Raul Torres, Ph.D.
LPA Regulation of T Cell Tumor Immunity
30,000
2011
Marileila Varella Garcia, Ph.D.
Cancer Research Summer Fellowship Program
30,000
2011
Christopher Porter, M.D. and Jean Mulcahy, M.D.
High Throughput Functional Genetic Screening to Define the Role of Autophagy in Pediatric Brain Tumors
60,000
2011
Henry Thompson, Ph.D. and Barbara Wallner, Ph.D.
Competency Development to Reduce Obesity and Promote Long Term Survival Following treatment for Breast Cancer
59,780
2011
Steve Anderson, Ph.D.
Does cell surface transporter expression determine the response of breast cancer
30,000
2011
Andrew Bradford, Ph.D.
PKCδ as a biomarker and regulator of response to chemotherapy in endometrial cancer
30,000
2011
Rytis Prekeris, Ph.D., and Pepper Schedin, Ph.D.
The regulation of MMP Secretion During the Invasion of Breast Cancer Cells
60,000
2011
Dylan Taatjes, Ph.D.
Identification of transcriptional cofactors that trigger alternations in breast cancer pathology and therapeutic response
30,000
2011
Lindsay Micel, M.D.
Identifying mechanisms of resistance to the novel NAE inhibitor, MLN4924, in melanoma
30,000
2011
Quinghong Zhang, Ph.D.
The Role of CtBP1 in SCC
30,000
2011
Dawn Cochrane, Ph.D.
Restoring miR-200c to aggressive ovarian cancers to attack anoikis resistance
30,000
2011
Pajon, Eduardo, Jr., M.D.
Colorado Cancer Research Clinical Trials Program
30,000
2011
Renee Paulson, Ph.D.
Elucidating the cellular response to hypoxia via functional genomics
30,000
2011